Literature DB >> 22947380

Monoamine theories of depression: historical impact on biomedical research.

Shai Mulinari1.   

Abstract

Monoamine theories associate depression with reduced brain monoamine levels. These theories achieved broad popularity in the mid-1960s. The present article reviews the historical development of monoamine theories and their subsequent impact on biomedical research. Alleged divisions between West European and US researchers over competing versions of the theories are investigated using bibliometrics. Subsequently, the application of monoamine theories in the NIMH Collaborative Program on the Psychobiology of Depression is covered. The article argues that the impact of monoamine theories is best explained by the ability of researchers, governmental agencies, and pharmaceutical companies to invoke theories that advance various projects and agendas.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22947380     DOI: 10.1080/0964704X.2011.623917

Source DB:  PubMed          Journal:  J Hist Neurosci        ISSN: 0964-704X            Impact factor:   0.529


  24 in total

Review 1.  Evidence for the role of corticotropin-releasing factor in major depressive disorder.

Authors:  R Parrish Waters; Marion Rivalan; D A Bangasser; J M Deussing; M Ising; S K Wood; F Holsboer; Cliff H Summers
Journal:  Neurosci Biobehav Rev       Date:  2015-08-10       Impact factor: 8.989

Review 2.  Dopamine in psychiatry: a historical perspective.

Authors:  Paul Bernard Foley
Journal:  J Neural Transm (Vienna)       Date:  2019-02-13       Impact factor: 3.575

3.  Stress-induced despair behavior develops independently of the Ahr-RORγt axis in CD4 + cells.

Authors:  Courtney R Rivet-Noor; Andrea R Merchak; Sihan Li; Rebecca M Beiter; Sangwoo Lee; Jalon Aaron Thomas; Anthony Fernández-Castañeda; Jung-Bum Shin; Alban Gaultier
Journal:  Sci Rep       Date:  2022-05-21       Impact factor: 4.996

4.  Conditioned task-set competition: Neural mechanisms of emotional interference in depression.

Authors:  Aleks Stolicyn; J Douglas Steele; Peggy Seriès
Journal:  Cogn Affect Behav Neurosci       Date:  2017-04       Impact factor: 3.282

Review 5.  Opposite effects of dopamine and serotonin on resting-state networks: review and implications for psychiatric disorders.

Authors:  Benedetta Conio; Matteo Martino; Paola Magioncalda; Andrea Escelsior; Matilde Inglese; Mario Amore; Georg Northoff
Journal:  Mol Psychiatry       Date:  2019-04-05       Impact factor: 15.992

6.  MAOB rs3027452 Modifies Mood Improvement After Tryptophan Supplementation.

Authors:  Irene Gonzalez; Rocio Polvillo; Maximiliano Ruiz-Galdon; Armando Reyes-Engel; Jose Luis Royo
Journal:  Int J Gen Med       Date:  2021-05-06

7.  Misleading advertising for antidepressants in Sweden: a failure of pharmaceutical industry self-regulation.

Authors:  Anna V Zetterqvist; Shai Mulinari
Journal:  PLoS One       Date:  2013-05-01       Impact factor: 3.240

8.  A Pill for the Ill? Patients' Reports of Their Experience of the Medical Encounter in the Treatment of Depression.

Authors:  Andreas Vilhelmsson; Tommy Svensson; Anna Meeuwisse
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

Review 9.  Dysregulation of adult hippocampal neuroplasticity in major depression: pathogenesis and therapeutic implications.

Authors:  Alexandria N Tartt; Madeline B Mariani; Rene Hen; J John Mann; Maura Boldrini
Journal:  Mol Psychiatry       Date:  2022-03-30       Impact factor: 13.437

Review 10.  Controversies about a common etiology for eating and mood disorders.

Authors:  Clara Rossetti; Olivier Halfon; Benjamin Boutrel
Journal:  Front Psychol       Date:  2014-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.